PotNetwork Holding, Inc. (POTN) Continues to Strengthen Advisory Board, Appoints Distinguished Medical Marijuana Certified Physician
PotNetwork Holding, Inc. (OTC Pink: POTN) today announces that as part of its strategy to formulate, produce and market a spectrum of exclusive and diversely targeted cannabidiol blends, the Company has appointed Dr. Michael McKenzie, industry leading physician, to the Company’s advisory board to empower management with valuable guidance, resources and insight as the Company mobilizes to serve the growing demand for premium medicinal grade products.
GT Biopharma Inc. (GTBP) Announces Completion of First Four Patients in FDA Phase 2 Trial of Cancer Drug OXS-1550
GT Biopharma Inc. (GTBP) (Euronext Paris: GTBP.PA) announced today that the first four patients have completed treatment in their Food and Drug Administration-approved (FDA) Phase 2 clinical trial of its promising cancer therapy, OXS-1550. Additional patient enrollment is ongoing.
A new study conducted in Illinois established a connection between medical marijuana and the consumption of opioids. The study was conducted by DePaul and Rush universities on 30 medical marijuana patients. They concluded that patients who used marijuana had a lower rate of opioid consumption.
GET UPDATES FASTER!
TEXT “MJSTOCKS” TO 474747 NOW!